https://doi.org/10.1016/s0140-6736(18)32409-7
T
Te‐Chun Hsia
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
162
Papers
9.5K
Citations
42
h-index
117
i10-index
Te‐Chun Hsia is an academic researcher from China Medical University. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Lung Cancer Research Studies & Lung Cancer Diagnosis and Treatment. The author has an h-index of 42, co-authored 138 publications.
Papers by this author
worksPembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
2019 · The Lancet · 3,270 citations
Lapatinib–induced NF-kappaB activation sensitizes triple-negative breast cancer cells to proteasome inhibitors
2013 · Breast Cancer Research · 73 citations
https://doi.org/10.1186/bcr3575
Lung cancer screening with low-dose computed tomography: Experiences from a tertiary hospital in Taiwan
2015 · Journal of the Formosan Medical Association · 41 citations
https://doi.org/10.1016/j.jfma.2015.11.007
Lapatinib-Mediated Cyclooxygenase-2 Expression via Epidermal Growth Factor Receptor/HuR Interaction Enhances the Aggressiveness of Triple-Negative Breast Cancer Cells
2013 · Molecular Pharmacology · 36 citations
https://doi.org/10.1124/mol.112.082743
Cigarette smoke-induced LKB1/AMPK pathway deficiency reduces EGFR TKI sensitivity in NSCLC
2020 · Oncogene · 35 citations
https://doi.org/10.1038/s41388-020-01597-1
Association of Interleukin-12A rs568408 with Susceptibility to Asthma in Taiwan
2017 · Scientific Reports · 26 citations
https://doi.org/10.1038/s41598-017-03523-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat